Description

Azitro SAN (azithromycin) powder for suspension 200 mg/5 ml. 30 ml. vial

Ingredients

Active ingredient: Azithromycin. Inactive ingredients may include sucrose, sodium phosphate, hydroxypropyl cellulose, and other excipients.

Dosage

Dosage: The recommended dose of Azitro SAN for most infections is 10 mg/kg once daily for 3 days. Consult a healthcare provider for the correct dosage based on the specific condition being treated.

Indications

Indications: Azitro SAN is indicated for the treatment of mild to moderate infections caused by susceptible strains of bacteria in various conditions such as respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases.

Contraindications

Contraindications: Do not use Azitro SAN if you have a known allergy to azithromycin or any macrolide antibiotics. It is important to inform your healthcare provider about any existing medical conditions or medications before starting Azitro SAN.

Directions

Directions: Shake the suspension well before each use. Measure the dose using the provided measuring device. Take Azitro SAN as directed by your healthcare provider. Do not skip doses or stop the medication early even if you feel better.

Scientific Evidence

Azithromycin, the active ingredient in Azitro SAN, has been extensively studied for its efficacy in treating various bacterial infections. Research studies have shown that azithromycin is effective in combating respiratory tract infections, skin infections, and sexually transmitted diseases. The drug works by inhibiting bacterial protein synthesis, leading to the eradication of the infecting bacteria.

Additional Information

Azitro SAN is generally well-tolerated, but some common side effects may include nausea, diarrhea, abdominal pain, and headache. It is important to complete the full course of treatment as prescribed by your healthcare provider to ensure the infection is fully treated and to prevent antibiotic resistance.

Pharmacologically, azithromycin acts by binding to the 50S ribosomal subunit of susceptible microorganisms, thereby interfering with microbial protein synthesis. This mechanism of action results in the inhibition of bacterial growth and the eventual death of the bacteria.

Clinical trials have demonstrated the effectiveness of Azitro SAN in comparison to other antibiotics in the treatment of respiratory infections and skin conditions. The drug’s convenient dosing regimen and broad spectrum of activity make it a preferred choice for many healthcare providers.